ISIS : Analysis & Opinions

  1. 3 Reasons Isis Is Worth Every Penny

    March 20, 2015
    While valuation metrics and earnings reports are the gold standard to understanding value in a vast majority of industries, ...
  2. Could This Drug Make Isis Pharmaceuticals Soar?

    March 11, 2015
    Warfarin has been doctors' go-to anticoagulant for decades, but recently launched next-generation anticoagulants are increasingly ...
  3. Is There An Upside For Isis Pharmaceutical Shares?

    February 26, 2015
    Shareholders in biotechnology company Isis Pharmaceuticals have endured a wild, but ultimately enjoyable, ride since late ...
  4. Trade Strong U.S. Small-Caps with this Bargain ETF

    January 29, 2015
    While most investors focus on the Swiss franc, quantitative easing or other global economic indicators, small-cap stocks ...
  5. How To Profit From These 3 Overvalued Sectors

    January 22, 2015
    Flea markets crack me up. Most of the vendors seem like they cleaned the junk from their garage and assigned an arbitrary, ...
  6. How the S&P 500 and Russell 2000 Indexes Differ

    January 22, 2015
    The S&P 500 and Russell 2000 are used as benchmarks for broader segments of the U.S. stock market. Each index has its own ...
  7. Big Mover Stocks With More Big Move Potential

    May 26, 2014
    These stocks had big price moves recently, and cosidering where the price is from a technical perspective, further big moves ...
  8. Alnylam Basking In Orphan Drug Attention

    May 28, 2013
    Alnylam has already seen a big run, but clinical success could bring even more gains.
  9. Healthcare Stocks, Including Pharmacyclics, Making Big Moves ...

    December 17, 2012
    On a good day for the market, the Nasdaq has risen 0.5%, the S&P 500 has increased 0.6% and the Dow has moved up 0.5%. ...
  10. Expedia and More Big Movers on the Nasdaq on September 21, 2 ...

    September 21, 2012
    This morning, the Nasdaq has moved little, the S&P 500 has decreased 0.3% and the Dow has been relatively flat. The recent ...
  11. Healthcare Sector's Biggest Movers: HCA Holdings and More

    August 6, 2012
    The market is currently up, with the Nasdaq climbing 1%, the S&P 500 rising 0.5% and the Dow up 0.6%. The healthcare ...
  12. XOMA Rearranges The Deck Chairs One More Time

    September 2, 2011
    XOMA changes management again, but should anybody care?
  13. A Deal At Last For Sanofi And Genzyme

    February 18, 2011
    Though Sanofi finally got its way in acquiring Genzyme, time will determine if stockholders will truly benefit.
  14. There Is Life After Death, At Least In Biotech

    June 22, 2010
    Clinical failure is not the end of the story for all biotechs. How do some survive while others disappear?
Trading Center